Brokerage firm Morgan Stanley maintained an overweight rating on Zomato while CLSA maintained a buy on Star Health. Also, Jefferies recommended a hold on Zydus Life and Morgan Stanley remained overweight on NYKAA. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Morgan Stanley on Zomato: Overweight| Target … Read more
TAQA Looks to Bet Big on Adani’s Power Biz Abu Dhabi National Energy Co. PJSC (TAQA) is looking to double down on India and is evaluating a large exposure in the expansive power businesses of Gautam Adani that span thermal generation to transmission, clean energy and green hydrogen, said people aware of the matter. Big … Read more
Mumbai: Rakesh Jhunjunwala-backed Concord Biotech launched its IPO Friday, joining the ranks of the late billionaire’s other private investment portfolio companies such as Star Health, Metro Brands and Nazara Technologies that have gone public in the past couple of years. The ace investor often called India’s Warren Buffet, first invested in Concord in 2004 and … Read more
SBI Card, M&M Financial and Nazara Tech have announced their first quarter results on Friday. Here’s a brief look at what the companies reported in Q1. SBI Card SBI Card’s net profit fell 5% year-on-year to Rs 593 crore in the June quarter as against Rs 627 crore in the same period last year. Total … Read more
The Indian stock market is trading at an all-time high as strong inflows from foreign and domestic investors rush in on the back of improved earnings and macroeconomic indicators. However, retail investors are in two minds: whether to book profits or continue investing. For investors looking for signs of real economic recovery, not just the … Read more
Adani Enterprises was the best performer on the Nifty50 in the week ended Friday, May 26 gaining over 30% during the five trading sessions. It was on the back of 61 block deals which fetched Rs 1,021 crore for the Ahmedabad-based company which has business interests in mining, solar manufacturing and water management among others. … Read more
“I think we are very comfortable with the price hike that we have taken. The sales team is geared up to convince the customers to ensure that there is no drop off,” says Anand Roy, MD, Star Health.You have taken 25% price hike across 50% of your book. Give us a perspective of as to … Read more
Nifty futures on the Singapore Exchange traded 278 points, or 1.61 per cent lower at 17,036, signaling that Dalal Street was headed for a negative start on Monday. Here are a dozen stocks which may buzz the most in today’s trade: : The Tata Group’s IT major will officially kick-off earning season of India Inc. … Read more
NEW DELHI: It was a strong week for Dalal Street that saw four of every five stocks from the broader index BSE500 ending higher amid easing oil prices and hopes the US Fed may slow down on rate hikes if the economy suffers big. As many as 23 index stocks surged 10-23 per cent during … Read more
Mumbai: Billionaire investors Rekha and Rakesh Jhunjhunwala‘s investment in IPO-bound Star Health and Allied Insurance jumped almost fivefold in two-and-a-half years to ₹8,500 crore, based on the upper end of the price band. Star Health is set to become the second-biggest stock in their portfolio of listed companies after Titan, with nearly 25% of the … Read more